Core Viewpoint - Runway Growth Finance (RWAY) is shifting from organic growth to M&A-driven growth, highlighted by the acquisition of SWK Holdings, which is expected to significantly enhance its portfolio and earnings power [1] Group 1: Acquisition and Growth Strategy - The acquisition of SWK Holdings is projected to scale RWAY's portfolio by approximately $242 million, increasing healthcare and life sciences exposure from 14% to about 31% of the portfolio at fair value [1] - Management anticipates mid-single-digit run rate net investment income (NII) accretion in the first full quarter following the acquisition's closure, expected in early 2026 [1] Group 2: Portfolio Performance - RWAY's total portfolio fair value decreased to $946 million from $1.02 billion, with Q3 2025 showing $199.7 million in repayments against $128.3 million in new funded loans [1] - Net asset value (NAV) per share fell to $13.55 from $13.66, indicating a contraction in the portfolio [1] Group 3: Dividend and Financial Metrics - The quarterly dividend has been reduced from $0.47 per share to $0.33 per share, but the Q3 NII per share of $0.43 covers the dividend at a ratio of 1.30x [1] - The debt portfolio yield increased to 16.8% from 15.4% in the previous quarter, with the stock currently yielding approximately 17.4% [1] Group 4: Market Context - The Federal Reserve has cut rates by 75 basis points over the past year, impacting floating-rate lenders like RWAY, although the company has experienced less spread compression compared to broader middle market peers [1]
CEO Said Organic Growth Is Over — Here's What Comes Next for RWAY